by telrheum | May 19, 2024 | Il-6 inhibitors, Hepatitis B, Infections, JAK Inhibitor
This study, presented at ACR Convergence 2023 by Akhil Sood, Janice Lin, and Neha Shah from Stanford University, examines the risk of Hepatitis B virus (HBV) reactivation in patients with rheumatoid arthritis (RA) who are being treated with either JAK inhibitors or...
by telrheum | May 19, 2024 | Biologic Therapy, Infections, Lupus, Rheumatoid Arthritis, Rituximab, Vasculitis
The article “Risk of Severe Infections Associated with Immunoglobulin Deficiency Under Rituximab Therapy in Immune Mediated Inflammatory Diseases” by Claire Rempenault and colleagues evaluates the connection between severe infections and immunoglobulin deficiency in...
by telrheum | May 18, 2024 | Uncategorized
The article titled “Herpes Zoster Prevalence in Patients with Rheumatic Diseases” from the ACR Convergence 2023, authored by a team led by Rodrigo J. Castillo-de la Garza, explores the occurrence of herpes zoster (commonly known as shingles) in patients...
by telrheum | May 17, 2024 | Hydroxychloroquine, Autoimmune Diseases
The article titled “The Prevalence and Risk Factors of Retinal Toxicity Associated with Long-term Hydroxychloroquine Use” by Sophie Do and colleagues from Kaiser SCAL, Fontana, CA, explores the eye-related side effects of hydroxychloroquine (HCQ), a...
by telrheum | May 10, 2024 | Autoimmune Diseases, Infections, Viral Infections
The article “Long Covid in Persons with Self-Reported Arthritis – Symptoms, Associated Factors and Functional Limitations” by Debbie Ehrmann Feldman and Barbara Mazer explores the impact of long Covid on individuals with arthritis. Presented at ACR...
